BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 1, 2025
See today's BioWorld Asia
See today's BioWorld
Home
» Chinese biotechs increasingly nimble in terms of deal structure
To read the full article
sign up for free
or
sign in
.
Chinabio Partnering Forum 2024
Chinese biotechs increasingly nimble in terms of deal structure
Sep. 10, 2024
By
Tamra Sami
No Comments
As geopolitical tensions rise between the U.S. and China, building cross-border relationships is more important than ever, said panelists during the Chinabio Partnering Forum in Shanghai Sept. 10.
BioWorld
BioWorld Asia
Conferences
Deals and M&A
ChinaBio Partnering Forum
Asia-Pacific
China
U.S.